ArticleSignal transduction and targeted therapy2021

Correction: Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway.

Lisha Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.